๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› USA
Clinical trial register · United States · industry-sponsored

Industry-sponsored studies with a US investigative site

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors โ€” the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice โ€” all 9112 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 23 Sep 2026, 03:16 UTC
9112
Studies in scope
industry-sponsored, all four open statuses
4950
Recruiting now
open to new participants
2202
Lead sponsors
across recruiting studies
Top states
California 5295 Florida 4397 Illinois 2479 Georgia 2346 Arizona 2231
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca299 Novartis Pharmaceuticals202 Eli Lilly and Company190 Merck Sharp & Dohme LLC183 AbbVie172
State
California5295 Florida4397 Illinois2479 Georgia2346 Arizona2231
All 51 states
Target enrolment
to
9112 of 9112 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Active, closed
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
NCT06506955Advanced/Metastatic Cancer
Taiho Oncology, Inc.
Phase 2/3
15
California
2024-10-01
Recruiting
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
NCT06634394Acute Myeloid Leukemia (AML)
Aptevo Therapeutics
Phase 1
39
Colorado, Florida, Kansas, Ohio, Texas
2024-10-01
Recruiting
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis
NCT06608134Osteoarthritis, Knee
R3 Medical Research
Phase EARLY_PHASE1
120
Arizona, California, New York, Texas
2024-10-01
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
NCT06510374Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals
Phase 3
454
Alabama, Arizona, Arkansas, California, Colorado, District of Columbia, Florida, Georgia
2024-10-01
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
NCT06545955Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Ferring Pharmaceuticals
Phase 3
250
Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia
2024-10-01
Recruiting
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naรฏve Participants Participants With Early Rheumatoid Arthritis
NCT06671054Rheumatoid Arthritis (RA)
SynAct Pharma Aps
Phase 2
240
Florida, Pennsylvania
2024-10-01
Recruiting
Post-Market Clinical Investigation of the IotaSOFT Insertion System
NCT06664697Hearing Loss, Cochlear, Cochlear Implantation, Hearing Loss, Sensorineural
iotaMotion, Inc.
Observational
50
Indiana, Iowa, Oregon
2024-10-01
Recruiting
Urine Metabolites in the Diagnosis of Disease
NCT06710067Colorectal Cancer, Small Intestinal Bacterial Overgrowth Syndrome (SIBO), Crohn Disease, Celiac Disease
Luventix, Inc.
Observational
1,250
California
2024-10-01
Recruiting
Safety and Effectiveness of Slow Wave Device for the Treatment of Obstructive Sleep Apnea
NCT06519149Obstructive Sleep Apnea
Slow Wave, Inc.
Observational
70
Texas
2024-10-01
Not yet open
Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients
NCT06039046Liposarcoma
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
Navigating the Clinical Research Process for Lymphoma
NCT06070246Lymphoma
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research
NCT06049485Follicular Lymphoma
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
Insights Into Participating in Studies for Bone Cancer
NCT06070259Bone Cancer
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
Patient Perspectives in Mantle Cell Lymphoma Clinical Research
NCT06049472Mantle Cell Lymphoma
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
NCT06029478Chondrosarcoma
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
NCT06029465Rhabdomyosarcoma
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
Fiber Product for Gas, Bloating, and Bowel Regularity
NCT06642766Bloating, Bowel Irregularities, Bowel Gas
Bell Cinical Service
Not applicable
100
Minnesota
2024-10
Not yet open
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
NCT06070272Recurrent Prostate Cancer
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns
NCT06039033Merkel Cell Carcinoma
Power Life Sciences Inc.
Observational
500
California
2024-10
Not yet open
A Full Face Study to Evaluate the Efficacy of Dermapen 4โ„ข Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.
NCT06602284Acne
Equipmed USA LLC
Phase 2/3
10
Alabama
2024-10
Not yet open
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
NCT06070285Recurrent Ovarian Cancer
Power Life Sciences Inc.
Observational
500
California
2024-10
Recruiting
A Study on TLC590 for Managing Postsurgical Pain
NCT06574269Postsurgical Pain Management
TLC Biopharmaceuticals, Inc.
Phase 2
120
Texas
2024-09-30
Recruiting
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
NCT06672692Influenza a, Influenza B, RSV, COVID 19
DiaSorin Molecular LLC
Not applicable
1,000
Nevada, Pennsylvania, Texas
2024-09-30
Recruiting
Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment
NCT06740799Hepatic Impairment
Daiichi Sankyo
Phase 1
12
Florida
2024-09-30
Active, closed
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
NCT06473779Severe Asthma
AstraZeneca
Phase 3
326
California, Colorado, Florida, Massachusetts, Missouri, New Jersey, Oklahoma, Texas
2024-09-30
Active, closed
A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent ฮฒ-thalassemia, Using MRI Scans to Measure Iron Levels in the Body
NCT06421636Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Regeneron Pharmaceuticals
Phase 2
19
New York
2024-09-30
Active, closed
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
NCT06602258Alzheimer's Disease
Eisai Inc.
Phase 2
105
Arizona, Connecticut, Florida, Georgia, Mississippi, Missouri, Pennsylvania, Tennessee
2024-09-30
Recruiting
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
NCT06551142Neoplasms
GlaxoSmithKline
Phase 1
845
California, Colorado, Connecticut, Indiana, Massachusetts, Michigan, New Jersey, South Carolina
2024-09-30
Active, closed
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
NCT06471543Hypertriglyceridemia, Familial Chylomicronemia Syndrome
Ikaria Bioscience Pty Ltd
Phase 1/2
108
Florida, Kentucky, Minnesota, Texas, Utah
2024-09-30
By invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
NCT06609239Asthma
Sanofi
Phase 2
900
Arizona, Colorado, Florida, Georgia, Massachusetts, Michigan, Missouri, North Carolina
2024-09-30
By invitation
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
NCT06657859Pmm2-CDG, Phosphomannomutase 2 Deficiency
Glycomine, Inc.
Phase 2
90
Minnesota, New York, Pennsylvania, Washington
2024-09-30
Recruiting
Phase III Presbyopia Correction Using the VIS Opti-Kโ„ข System
NCT06487897Presbyopia
VIS, Inc.
Phase 3
75
Florida, Massachusetts, New Jersey, New York
2024-09-30
Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698Liver Diseases, Alcoholic
GlaxoSmithKline
Phase 2
393
Arizona, California, Florida, Georgia, Indiana, Kansas, Louisiana, Michigan
2024-09-27
Recruiting
Registry for Stage 2 Type 1 Diabetes
NCT06481904Type 1 Diabetes
Sanofi
Observational
200
California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky
2024-09-27
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616Breast Cancer
Stemline Therapeutics, Inc.
Phase 3
4,220
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida
2024-09-27
Recruiting
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
NCT06584357Mild Cognitive Impairment, Alzheimer's Disease, Alzheimer's Disease, Early Onset, Memory Loss
GAP Innovations, PBC
Observational
1,200
Florida, Illinois, Michigan, Nevada, New York, Ohio, Pennsylvania, Rhode Island
2024-09-26
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Arizona, California, Connecticut, Florida, Georgia, Massachusetts, Michigan, Mississippi
2024-09-26
Recruiting
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
NCT06539507Netherton Syndrome
BioCryst Pharmaceuticals
Phase 1
78
California, Connecticut, Illinois, Indiana
2024-09-26
Active, closed
TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (TRINITY-US)
NCT06568003Tricuspid Regurgitation (TR)
Jenscare Innovation Inc.
Not applicable
15
California, Michigan, New York
2024-09-26
Recruiting
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
NCT06463665Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer, Metastatic Squamous Non-Small Cell Lung Carcinoma
Genelux Corporation
Phase 2
142
Arizona, Florida, Michigan, New Jersey, Ohio, Texas
2024-09-26
Active, closed
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEMโ„ข Primary Hip System
NCT06564636Total Hip Arthroplasty (THA), Osteoarthritis, Degenerative Joint Disease, Inflammatory Arthritis
Smith & Nephew, Inc.
Observational
119
California, Connecticut, Florida, Illinois, New York, North Carolina
2024-09-26
Active, closed
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
NCT06564194Respiratory Syncytial Virus (RSV), Infectious Disease
Immorna Biotherapeutics, Inc.
Phase 1
75
Florida, Louisiana, Missouri
2024-09-25
Active, closed
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394Dravet Syndrome
Longboard Pharmaceuticals
Phase 3
96
Arkansas, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Maryland
2024-09-25
Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
NCT06462235Gram-negative Bacterial Infection
Pfizer
Phase 2
48
California, Colorado, Indiana, Kentucky, Massachusetts, North Carolina, Texas
2024-09-25
Recruiting
A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems
NCT06512454Alpha1-Antitrypsin Deficiency
Takeda
Observational
500
Florida, South Carolina, Tennessee
2024-09-25
Recruiting
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
NCT06525220Head and Neck Squamous Cell Carcinoma
Merus B.V.
Phase 3
700
Alabama, California, Delaware, District of Columbia, Florida, Georgia, Illinois, Kentucky
2024-09-25
Recruiting
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREEยฎ) in Patients With Duchenne Muscular Dystrophy-SUMMIT
NCT06564974Duchenne Muscular Dystrophy
Catalyst Pharmaceuticals, Inc.
Observational
250
Arizona, Arkansas, California, District of Columbia, Florida, Illinois, Indiana, Kansas
2024-09-25
Active, closed
ADVENT Post Approval Study
NCT06431815Paroxysmal Atrial Fibrillation
Boston Scientific Corporation
Observational
228
Alabama, Arizona, California, District of Columbia, Florida, Georgia, Louisiana, Massachusetts
2024-09-25
Active, closed
Preventing Medication Mismanagement in People Living with Dementia Through Automated Medication Dispensing with Facial Recognition and Video Observation
NCT06691256Alzheimer Disease, Dementia, Medication Adherence, Type 2 Diabetes Mellitus (T2DM)
HiDO Technologies
Phase 2
70
Illinois
2024-09-24
Active, closed
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants โ‰ฅ18 Years of Age for the Prevention of Acute Gastroenteritis
NCT06592794Acute Gastroenteritis, Norovirus Acute Gastroenteritis
ModernaTX, Inc.
Phase 3
37,864
Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho
2024-09-24
Active, closed
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
NCT06436742Congenital Myasthenic Syndrome, CMS
argenx
Phase 1
15
California, Illinois
2024-09-24
Active, closed
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough
NCT06504446Refractory or Unexplained Chronic Cough
Nocion Therapeutics
Phase 2
455
Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois
2024-09-24
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
Lexicon Pharmaceuticals
Phase 3
500
Arizona, California, Florida, Georgia, Illinois, Indiana, Maryland, Massachusetts
2024-09-24
Recruiting
Evaluate the Safety and Effectiveness of the AccuraSeeโ„ข IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery
NCT06625749Refractive Surgery, Refractive Error - Myopia
OnPoint Vision Inc
Not applicable
10
Ohio
2024-09-23
Recruiting
Non-Euploid Embryo Transfer (NEET) Registry
NCT07036536Infertility, Mosaicism, Aneuploidy
Inception Fertility Research Institute, LLC
Observational
1,000
Texas
2024-09-23
Active, closed
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06497556Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Hoffmann-La Roche
Phase 3
338
Arizona, California, Connecticut, Florida, Illinois, Maine, Massachusetts, Michigan
2024-09-23
Recruiting
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
NCT06375278Cochlear Implants, Cochlear Implantation, Hearing Loss
Restorear Devices LLC
Not applicable
54
Florida
2024-09-23
Recruiting
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
NCT06550596Diabetic Foot, Ulcer Foot, Foot Ulcer, Diabetic Foot Ulcer
Axolotl Biologix
Not applicable
100
California
2024-09-23
Active, closed
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
NCT06555796Prostate Cancer, High-risk Biochemical Recurrence, High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer, Non-metastatic Castration-sensitive Prostate Cancer
Amgen
Phase 1
50
Minnesota, New York, North Carolina, Oregon, Pennsylvania, Texas, Washington
2024-09-23
Not yet open
Effect of a Nutritional Supplement on Gut Microbiota in Adults
NCT06611215Changes in Gut Microbiota with Prebiotic Supplementation, Quality of Life
Pharmavite LLC
Not applicable
80
Illinois
2024-09-23
Recruiting
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
NCT06413680Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC), Advanced Solid Tumors
Regeneron Pharmaceuticals
Phase 1/2
240
California, Connecticut, Illinois, Michigan, New York, North Carolina, Pennsylvania, Texas
2024-09-23
Recruiting
A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT
NCT05171894Port-wine Birthmarks, Port-Wine Stain, Nevus Flammeus
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 2
84
California, Florida, Maryland, Pennsylvania
2024-09-21
Recruiting
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
NCT06598007Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
Crossignal Therapeutics, Inc.
Phase 1/2
78
Texas
2024-09-20
Recruiting
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
NCT06564831Diabetic Foot Ulcer, Diabetic Foot, Foot Ulcer, Ulcer Foot
Applied Biologics, LLC
Not applicable
124
Michigan
2024-09-20
Active, closed
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
NCT06553027Parkinson Disease
Cerevance
Phase 3
330
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Kansas
2024-09-20
Recruiting
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
NCT06633016Major Depressive Disorder
Autobahn Therapeutics, Inc.
Phase 2
230
Alabama, Arizona, California, Connecticut, Florida, Georgia, Illinois, Massachusetts
2024-09-20
Recruiting
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
NCT06469944Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
Merck Sharp & Dohme LLC
Phase 1/2
160
Arizona, California, Kentucky, Michigan, New York, Pennsylvania, Texas
2024-09-20
Active, closed
KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
NCT06384976Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, MS
Kyverna Therapeutics
Phase 2
120
California
2024-09-20
Active, closed
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
NCT06603571Obesity, Overweight
Eli Lilly and Company
Phase 2
367
Arizona, California, Connecticut, Florida, Idaho, Illinois, Iowa, Kansas
2024-09-20
Recruiting
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT06586957Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult, Metastatic Tumor
NiKang Therapeutics, Inc.
Phase 1
150
Arkansas, California, Colorado, Florida, Georgia, Kansas, Massachusetts, New Jersey
2024-09-19
Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
NCT06561685Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer, SMARCA4-Deficient Tumor
Eli Lilly and Company
Phase 1
340
California, Colorado, Florida, Illinois, Massachusetts, New York, Ohio, Tennessee
2024-09-19
Active, closed
A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World
NCT06728319Lung Nodules
Biodesix, Inc.
Observational
4,000
Florida, Kentucky, Massachusetts, Pennsylvania
2024-09-19
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06635148Geographic Atrophy, Macular Degeneration
Janssen Research & Development, LLC
Phase 2/3
274
Arizona, California, Florida, Georgia, Illinois, Indiana, Maine, Maryland
2024-09-19
Recruiting
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
NCT06606210Wound Heal, Venous Leg Ulcer
ConvaTec Inc.
Not applicable
120
Florida
2024-09-19
Active, closed
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis
NCT06558279Myasthenia Gravis, Ocular
argenx
Phase 3
141
Arizona, California, Florida, Illinois, Maryland, Massachusetts, Michigan, New Jersey
2024-09-18
Active, closed
A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma
NCT06190951Melanoma
Regeneron Pharmaceuticals
Phase 2
151
California, Colorado, Connecticut, Georgia, Illinois, Massachusetts, Missouri, New Jersey
2024-09-18
Recruiting
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
NCT06542250B-cell Malignancies
AstraZeneca
Phase 1/2
174
California, Massachusetts, Minnesota, New Jersey, New York, North Carolina, Texas, Washington
2024-09-18
Active, closed
NS-050/NCNP-03 in Boys With DMD (Meteor50)
NCT06053814Duchenne Muscular Dystrophy
NS Pharma, Inc.
Phase 1/2
20
California, Colorado, Illinois, Kansas, Pennsylvania
2024-09-18
Active, closed
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
NCT06571383Obesity
Novo Nordisk A/S
Phase 4
500
California, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Louisiana
2024-09-17
Active, closed
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
NCT06333951Thoracic Tumors, Non-small Cell Lung Cancer
Amgen
Phase 1
49
California, Colorado, Connecticut, Minnesota, Missouri, Nevada, New York, Oklahoma
2024-09-17
Active, closed
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06589986Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche
Phase 3
400
Alabama, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana
2024-09-17
Recruiting
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
NCT06567015Non-small Cell Lung Cancer (NSCLC)
Pierre Fabre Medicament
Phase 1/2
171
Tennessee, Texas
2024-09-17
Recruiting
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT06398626Colitis, Ulcerative
Pfizer
Observational
300
Arizona, California, Colorado, Florida, Illinois, Maryland, New Jersey, New York
2024-09-17
Active, closed
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
NCT06497504Hepatitis B
GlaxoSmithKline
Phase 2
153
California, Florida, Maryland, Minnesota, New Jersey
2024-09-17
Active, closed
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
NCT06559163Systemic Lupus Erythematosus
Zenas BioPharma (USA), LLC
Phase 2
190
Arizona, California, Connecticut, Florida, Georgia, Illinois, Louisiana, Maryland
2024-09-17
Active, closed
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
NCT06892938Atrial Fibrillation (AF), Arrhythmias Cardiac, Tachycardia, Palpitations
Everbeat
Observational
232
California, Louisiana, Pennsylvania
2024-09-17
Active, closed
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NCT06293482Hearing Loss, Sensorineural, Hearing Loss, Bilateral
Cochlear
Not applicable
50
Arizona, California, Florida, Indiana, Missouri, New York, Ohio, Pennsylvania
2024-09-17
Active, closed
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
NCT06537999Multifocal Motor Neuropathy
Dianthus Therapeutics
Phase 2
46
Arizona, California, Florida, Hawaii, Kansas, Ohio, Texas
2024-09-17
Recruiting
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
NCT06724627Skin Condition, Dermatology, Dermatology/Skin - Other
BelleTorus Corporation
Not applicable
263
New York
2024-09-16
Recruiting
Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses
NCT06539936Amputation, Upper Limb
Infinite Biomedical Technologies
Not applicable
7
California
2024-09-16
Recruiting
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
NCT06140524Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals
Phase 2
116
Maryland, Massachusetts, Michigan, New York, Pennsylvania, Washington
2024-09-16
Active, closed
A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
NCT06550895Multiple Myeloma
Janssen Research & Development, LLC
Phase 2
11
Iowa, Kentucky, Michigan, New York, Pennsylvania
2024-09-16
Recruiting
A Study of VET3-TGI in Patients With Solid Tumors
NCT06444815Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer
KaliVir Immunotherapeutics
Phase 1
60
California, Florida, Indiana, Pennsylvania, Texas
2024-09-16
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
NCT06567743High-Risk Non-Muscle-Invasive Bladder Cancer
CG Oncology, Inc.
Phase 2
325
Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois, Indiana
2024-09-16
Not yet open
The VIS Opti-K Low Vision Aid Device Provides Vision Improvement.
NCT06597292Hyperopia, Presbyopia
VIS, Inc.
Not applicable
200
Texas
2024-09-16
Recruiting
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
NCT06526923Cystic Fibrosis
Spirovant Sciences, Inc.
Phase 1/2
15
Kansas, Massachusetts, New York, Pennsylvania
2024-09-16
Active, closed
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
NCT06615557Social Anxiety Disorder (SAD)
VistaGen Therapeutics, Inc.
Phase 3
238
Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois, Massachusetts
2024-09-16
Recruiting
Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) Symptoms
NCT06613438GERD (Gastroesophageal Reflux Disease)
Gerd Care Medical Ltd
Not applicable
84
Illinois
2024-09-15
Recruiting
Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis
NCT06053255Sacroiliitis
FUSMobile Inc.
Not applicable
10
Virginia
2024-09-13
Recruiting
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
NCT06388707Drug Resistant Epilepsy, Epilepsy, Seizures, Focal, Seizure
NaviFUS Corporation
Phase 1/2
8
California, Massachusetts, Virginia
2024-09-13
Rows per page Showing 4601–4700 of 9112
Previous 45 46 47 48 49 Next
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-usa?page=47

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →
→

Browse trials by condition

Advanced Solid Tumor (143) Breast Cancer (139) Obesity (123) Multiple Myeloma (109) Advanced Solid Tumors (89) Colorectal Cancer (83) Solid Tumor (81) Overweight (77) Ovarian Cancer (74) Healthy (73) Prostate Cancer (73) Heart Failure (72) Non-Small Cell Lung Cancer (70) Cancer (65) Melanoma (63)
→

Browse trials by state

California (5295) Florida (4397) Illinois (2479) Georgia (2346) Arizona (2231) New York (2126) Colorado (2066) Texas (1969) Massachusetts (1836) Michigan (1481) Alabama (1288) Connecticut (1274) Maryland (1267) Ohio (1252) Indiana (1114)
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.